Author

Margaret Haughton

Observed institutions: Australian and New Zealand Intensive Care Society, Johnson & Johnson (Australia)

OpenAlex ID: A5000474795

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

2009 · Ronald T Mitsuyasu, Thomas C Merigan, et al. · Nature Medicine · 263

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

2020 · Jason A Roberts, Gavin M Joynt, et al. · Clinical Infectious Diseases · 152

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy

2026 · Marta Ulldemolins, Jeffrey Lipman, et al. · Critical Care · 1

Works count: 4

Citation count: 416

H-index: 2

I10-index: 2